Coronary Guidewires - Medical Devices Pipeline Assessment, 2018

Region:Global

Author(s):

Product Code:GDME0568EPD

Download Sample Report download
Buy the Full ReportStarting from $2500
Published on

June 2018

Total pages

102

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2500

About the Report

About the Report

Coronary Guidewires-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Coronary Guidewires-Medical Devices Pipeline Assessment, 2018" provides an overview of Coronary Guidewires currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Coronary Guidewires under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Coronary Guidewires under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Products

Products

Bioscan Technologies Inc., Lightwire; Boston Scientific Corp, Crossing Wire; CardioSert Ltd., CardioSert CTO Tool; Cardiovascular Systems Inc, ZILIENT Guidewire - Coronary Intervention; ENDOMATERIALS, Multimodal Sensing Guidewire; Georgia Institute of Technology, Intravascular Ultrasound Imaging Guidewire; Guided Interventions, LLC, Pressure Sensing Coronary Artery Guide Wire; Infrared Sciences Corp., Steerable Guidewire; MaRVis Technologies GmbH, MaRVis 0.014 Micro Guidewire; MaRVis Technologies GmbH, MaRVis 0.035" Standard And Stiff Guidewire; MicroPort Scientific Corp, Micro-Guide Wire; OVALUM Ltd, OctoBooster Extension Guidewire; SoundBite Medical Solutions Inc, SoundBite Active Wire - Coronary; St. Jude Medical LLC, Sensor Enabled - Quadra Excel Guidewire; Terumo Interventional Systems, Wrist Artery Guidewire; Three Rivers Cardiovascular Systems Inc, SmartGuidewire; University of Illinois at Chicago, CTO Wire; Vasostar Ltd., Vibrational Guidewire System


Companies

Bioscan Technologies Inc.

Boston Scientific Corp

CardioSert Ltd.

Cardiovascular Systems Inc

ENDOMATERIALS

Georgia Institute of Technology

Guided Interventions, LLC

Infrared Sciences Corp.

MaRVis Technologies GmbH

MicroPort Scientific Corp

OVALUM Ltd

SoundBite Medical Solutions Inc

St. Jude Medical LLC

Terumo Interventional Systems

Three Rivers Cardiovascular Systems Inc

University of Illinois at Chicago

Vasostar Ltd.

Table of Contents

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Coronary Guidewires Overview 7

3 Products under Development 8

3.1 Coronary Guidewires-Pipeline Products by Stage of Development 8

3.2 Coronary Guidewires-Pipeline Products by Territory 9

3.3 Coronary Guidewires-Pipeline Products by Regulatory Path 10

3.4 Coronary Guidewires-Pipeline Products by Estimated Approval Date 11

4 Coronary Guidewires-Pipeline Products under Development by Companies 12

4.1 Coronary Guidewires Companies-Pipeline Products by Stage of Development 12

4.2 Coronary Guidewires-Pipeline Products by Stage of Development 13

5 Coronary Guidewires Companies and Product Overview 14

5.1 Bioscan Technologies Inc. Company Overview 14

5.1.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Boston Scientific Corp Company Overview 15

5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 CardioSert Ltd. Company Overview 16

5.3.1 CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Cardiovascular Systems Inc Company Overview 17

5.4.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.5 ENDOMATERIALS Company Overview 18

5.5.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 18

5.6 Georgia Institute of Technology Company Overview 19

5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19

5.7 Guided Interventions, LLC Company Overview 20

5.7.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.8 Infrared Sciences Corp. Company Overview 21

5.8.1 Infrared Sciences Corp. Pipeline Products & Ongoing Clinical Trials Overview 21

5.9 MaRVis Technologies GmbH Company Overview 22

5.9.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 22

5.10 MicroPort Scientific Corp Company Overview 24

5.10.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.11 OVALUM Ltd Company Overview 25

5.11.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.12 SoundBite Medical Solutions Inc Company Overview 26

5.12.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.13 St. Jude Medical LLC Company Overview 27

5.13.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.14 Terumo Interventional Systems Company Overview 28

5.14.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 28

5.15 Three Rivers Cardiovascular Systems Inc Company Overview 29

5.15.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.16 University of Illinois at Chicago Company Overview 30

5.16.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 30

5.17 Vasostar Ltd. Company Overview 31

5.17.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31

6 Coronary Guidewires- Recent Developments 32

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 32

6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 34

6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 34

6.4 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 35

6.5 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 35

6.6 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 36

6.7 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 38

6.8 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 39

6.9 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 41

6.10 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 42

6.11 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 43

6.12 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 45

6.13 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 46

6.14 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 48

6.15 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 49

6.16 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 49

6.17 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 50

6.18 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 52

6.19 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices 52

6.20 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 53

6.21 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 55

6.22 Jan 23, 2018: Opsens Announces Election Results for the Board of Directors and the Retirement of Claude Belleville 57

6.23 Jan 15, 2018: Opsens Reports Q1 2018 Results-Record Quarterly Revenues With Growth in all Geographic Regions 58

6.24 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 59

6.25 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 59

6.26 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 60

6.27 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 61

6.28 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 62

6.29 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 62

6.30 Nov 15, 2017: Opsens Reports 2017 Results-Consolidated Revenues Up 85% for Fiscal 2017 65

6.31 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 66

6.32 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 67

6.33 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 68

6.34 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 70

6.35 Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 71

6.36 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 74

6.37 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 74

6.38 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 75

6.39 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 76

6.40 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 77

6.41 Sep 22, 2017: Abbott and the Abbott Fund Provide USD 2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico 78

6.42 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With USD 1 Million to Help Families Affected by Hurricane Irma 79

6.43 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 79

6.44 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 81

6.45 Aug 29, 2017: Abbott and the Abbott Fund Donate USD 1 Million to Support Hurricane Harvey Relief Efforts 82

6.46 Aug 29, 2017: Abbott Issues New Updates for Implanted Cardiac Devices 82

6.47 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 83

6.48 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 86

6.49 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 86

6.50 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 86

6.51 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 87

6.52 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 89

6.53 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 90

6.54 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 91

6.55 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 93

6.56 Jul 07, 2017: MPSC New COO Glendy Wang on Board 95

6.57 Jun 29, 2017: Opsens Reports Q3 2017 Results-Another Record Quarter with Revenues Up 130% to USD 4.9 Million 95

6.58 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 96

6.59 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 98

6.60 Jun 07, 2017: Robin Villeneuve Appointed as Chief Financial Officer 98

7 Appendix 99

7.1 Methodology 99

7.2 About GlobalData 102

7.3 Contact Us 102

7.4 Disclaimer 102


List of Figure

1.2 List of Figures

Figure 1: Coronary Guidewires-Pipeline Products by Stage of Development 8

Figure 2: Coronary Guidewires-Pipeline Products by Territory 9

Figure 3: Coronary Guidewires-Pipeline Products by Regulatory Path 10

Figure 4: Coronary Guidewires-Pipeline Products by Estimated Approval Date 11


List of Table

1.1 List of Tables

Table 1: Coronary Guidewires-Pipeline Products by Stage of Development 8

Table 2: Coronary Guidewires-Pipeline Products by Territory 9

Table 3: Coronary Guidewires-Pipeline Products by Regulatory Path 10

Table 4: Coronary Guidewires-Pipeline Products by Estimated Approval Date 11

Table 5: Coronary Guidewires Companies-Pipeline Products by Stage of Development 12

Table 6: Coronary Guidewires-Pipeline Products by Stage of Development 13

Table 7: Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 8: Lightwire-Product Status 14

Table 9: Lightwire-Product Description 14

Table 10: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 15

Table 11: Crossing Wire-Product Status 15

Table 12: Crossing Wire-Product Description 15

Table 13: CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16

Table 14: CardioSert CTO Tool-Product Status 16

Table 15: CardioSert CTO Tool-Product Description 16

Table 16: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Table 17: ZILIENT Guidewire-Coronary Intervention-Product Status 17

Table 18: ZILIENT Guidewire-Coronary Intervention-Product Description 17

Table 19: ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 18

Table 20: Multimodal Sensing Guidewire-Product Status 18

Table 21: Multimodal Sensing Guidewire-Product Description 18

Table 22: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19

Table 23: Intravascular Ultrasound Imaging Guidewire-Product Status 19

Table 24: Intravascular Ultrasound Imaging Guidewire-Product Description 19

Table 25: Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Table 26: Pressure Sensing Coronary Artery Guide Wire-Product Status 20

Table 27: Pressure Sensing Coronary Artery Guide Wire-Product Description 20

Table 28: Infrared Sciences Corp. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 29: Steerable Guidewire-Product Status 21

Table 30: Steerable Guidewire-Product Description 21

Table 31: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 22

Table 32: MaRVis 0.014 Micro Guidewire-Product Status 22

Table 33: MaRVis 0.014 Micro Guidewire-Product Description 22

Table 34: MaRVis 0.035" Standard And Stiff Guidewire-Product Status 23

Table 35: MaRVis 0.035" Standard And Stiff Guidewire-Product Description 23

Table 36: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Table 37: Micro-Guide Wire-Product Status 24

Table 38: Micro-Guide Wire-Product Description 24

Table 39: OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Table 40: OctoBooster Extension Guidewire-Product Status 25

Table 41: OctoBooster Extension Guidewire-Product Description 25

Table 42: SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 43: SoundBite Active Wire-Coronary-Product Status 26

Table 44: SoundBite Active Wire-Coronary-Product Description 26

Table 45: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Table 46: Sensor Enabled-Quadra Excel Guidewire-Product Status 27

Table 47: Sensor Enabled-Quadra Excel Guidewire-Product Description 27

Table 48: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 28

Table 49: Wrist Artery Guidewire-Product Status 28

Table 50: Wrist Artery Guidewire-Product Description 28

Table 51: Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 52: SmartGuidewire-Product Status 29

Table 53: SmartGuidewire-Product Description 29

Table 54: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 30

Table 55: CTO Wire-Product Status 30

Table 56: CTO Wire-Product Description 30

Table 57: Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 58: Vibrational Guidewire System-Product Status 31

Table 59: Vibrational Guidewire System-Product Description 31

Table 60: Glossary 101

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022